Semantic search
Jump to navigation
Jump to search
| Issue date | From | Title | Project stage | |
|---|---|---|---|---|
| ML20323A407 | 18 November 2020 | Andrew Hon NRC/NRR/DORL/LPL2-2 | NRR E-mail Capture - Request for Additional Information - Brunswick License Exemption Request from 10CFR73 Annual Force on Force Exercise Requirements (EPIC L-2020-LLE-0180) | RAI |
| ML20330A321 | 9 December 2020 | Division of Operating Reactor Licensing Craig Erlanger | Exemption Form Annual Force-on-Force Exercise Requirements of 10 CFR Part 73, Appendix B, General Criteria for Security Personnel, Subsection VI.C.3(I)(1) (EPID L-2020-LLE-0180) (COVID-19) | Other |
| ML20338A329 | 17 December 2020 | Plant Licensing Branch II Caroline Carusone | Exemption from Annual Force-On-Force Exercise Requirements of 10 CFR Part 73, Appendix B, General Criteria for Security Personnel, Subsection VI.C.3(I)(1) (EPID L-2020-LLE-0180 (Covid 19)) | Approval |
| ML20337A128 | 17 December 2020 | Division of Operating Reactor Licensing Caroline Carusone | Exemption from Annual Force-On-Force Exercise Requirements of 10 CFR Part 73, Appendix B, General Criteria for Security Personnel, Subsection Vi.C.3(I)(1)(EPID L-2020-Lle-0180 (Covid 19)) | Approval |
| ML20339A521 | 17 December 2020 | Division of Operating Reactor Licensing Caroline Carusone | Exemption from Annual Force-On-Force Exercise Requirements of 10 CFR Part 73, Appendix B, General Criteria for Security Personnel, Subsection VI.C.3(I)(1) | Approval |
| ML20344A004 | 17 December 2020 | Plant Licensing Branch II Caroline Carusone | Exemption from Annual Force-On-Force Exercise Requirements of 10 CFR Part 73, Appendix B, General Criteria for Security Personnel, Subsection VI.C.3(I)(1) (EPID L-2020-LLE-0180 (Covid 19)) | Approval |
| ML20330A301 | 17 December 2020 | Division of Operating Reactor Licensing Caroline Carusone | Exemption from Annual Force-on-Force Exercise Requirements of 10 CFR Part 73, Appendix B, General Criteria for Security Personnel, Subsection VI.C.3(l)(1) (EPID L-2020-LLE-0180 (COVID-19)) | Approval |